{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Complete Response (CR) defined as all of the following for a minimum of 2 months: a) absence of urine and serum M-components by immunofixation; b) bone marrow should be adequately cellular (\\>20%); c) normal serum calcium; d) no new bone lesions or enlargement of existing lesions.\n\nNear Complete Response included all elements of CR except immunofixation studies remained positive.","groups":[{"description":"1. High dose DTPACE and stem cell collection if you do not already have sufficient stem cells stored\n2. High dose DTPACE and stem cell re-infusion\n3. VTD Maintenance therapy","id":"OG000","title":"HD DTPACE"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"12 months","title":"Number of Subjects Treated With (HD DTPACE Obtain a Complete Response or Near Complete Response That Lasts for 6 Months or Longer.","type":"PRIMARY","unitOfMeasure":"participant response"}